Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ATSM<.>)
Общее количество найденных документов : 23
Показаны документы с 1 по 20
 1-20    21-23 
1.
Vavere Amy L. Cu-ATSM: A radiopharmaceutical for the PET imaging of hypoxia // Dalton Trans., 2007, N 43.-С.4893-4902

2.
Evaluation of copper-62 ATSM in patients with lung cancer as a hypoxic tissue tracer // J. Nucl. Med., 1998. Vol. 39, N 5 Suppl..-С.53

3.
Evaluation of copper-62 ATSM in patients with lung cancer as a hypoxic tissue tracer // J. Nucl. Med., 1998. Vol. 39, N 5 Suppl..-С.53

4.
Evaluation of rapid dual-tracer {62}Cu-PTSM+ {62}Cu-ATSM PET in dogs with spontaneously occurring tumors // Phys. Med. and Biol., 2008. Vol. 53, N 1.-С.217-232

5.
Evaluation of rapid dual-tracer {62}Cu-PTSM+ {62}Cu-ATSM PET in dogs with spontaneously occurring tumors // Phys. Med. and Biol., 2008. Vol. 53, N 1.-С.217-232

6.
Imaging hypoxia in vivo by controlling the electrochemistry of copper radionuclide complexes // J. Labell. Compounds and Radiopharm., 2007. Vol. 50, N 5-6.-С.354-359

7.
In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals // Phys. Med. and Biol., 2009. Vol. 54, N 7.-С.2103-2119

8.
In vivo assessment of tumor hypoxia in lung cancer with {60}Cu-ATSM // Eur. J. Nucl. Med. and Mol. Imag., 2003. Vol. 30, N 6.-С.844-850

9.
In vivo assessment of tumor hypoxia in lung cancer with {60}Cu-ATSM // Eur. J. Nucl. Med. and Mol. Imag., 2003. Vol. 30, N 6.-С.844-850

10.
Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting // Phys. Med. and Biol., 2008. Vol. 53, N 15.-С.4153-4167

11.
Intratumoral administration of {64}Cu-ATSM or {61}Cu-ATSM: Therapeutic comparison in GW39 tumors // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.279

12.
Intratumoral administration of {64}Cu-ATSM or {61}Cu-ATSM: Therapeutic comparison in GW39 tumors // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.279

13.
Intratumoral administration of {64}Cu-ATSM or {61}Cu-ATSM: Therapeutic comparison in GW39 tumors // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.279

14.
MicroPET imaging of the effects of tumorcidal-2-deoxyglucose // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.80

15.
MicroPET imaging of the effects of tumorcidal-2-deoxyglucose // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.80

16.
MicroPET imaging of the effects of tumorcidal-2-deoxyglucose // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.80

17.
On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function // Phys. Med. and Biol., 2009. Vol. 54, N 6.-С.1483-1501

18.
Practical production of {61}Cu via {nat}Co (a, 2n) {61}Cu reaction and preparation of {61}Cu-ATSM // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.286

19.
Practical production of {61}Cu via {nat}Co (a, 2n) {61}Cu reaction and preparation of {61}Cu-ATSM // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.286

20.
Predicting location of recurrence using FDG, FLT, and Cu-ATSM PET in canine sinonasal tumors treated with radiotherapy // Phys. Med. and Biol., 2015. Vol. 60, N 13.-С.5211-5224

 1-20    21-23 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)